Literature DB >> 16145166

Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.

Miguel Viveiros1, Clara Leandro, Liliana Rodrigues, Josefina Almeida, Rosário Bettencourt, Isabel Couto, Lurdes Carrilho, José Diogo, Ana Fonseca, Luís Lito, João Lopes, Teresa Pacheco, Mariana Pessanha, Judite Quirim, Luísa Sancho, Max Salfinger, Leonard Amaral.   

Abstract

The INNO-LiPA Rif.TB assay for the identification of Mycobacterium tuberculosis complex strains and the detection of rifampin (RIF) resistance has been evaluated with 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis (MDR-TB). The sensitivity when compared to conventional identification/culture methods was 82.2%, and the specificity was 66.7%; the sensitivity and specificity were 100.0% and 96.9%, respectively, for the detection of RIF resistance. This assay has the potential to provide rapid information that is essential for the effective management of MDR-TB.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145166      PMCID： PMC1234138          DOI： 10.1128/JCM.43.9.4880-4884.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  29 in total

1.  Discrimination of multidrug-resistant Mycobacterium tuberculosis IS6110 fingerprint subclusters by rpoB gene mutation analysis.

Authors:  I Portugal; S Maia; J Moniz-Pereira
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy.

Authors:  T C Victor; A M Jordaan; A van Rie; G D van der Spuy; M Richardson; P D van Helden; R Warren
Journal:  Tuber Lung Dis       Date:  1999

Review 3.  Laboratory diagnosis of mycobacterial infections: new tools and lessons learned.

Authors:  Y M Hale; G E Pfyffer; M Salfinger
Journal:  Clin Infect Dis       Date:  2001-08-13       Impact factor: 9.079

4.  Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Authors:  Z Bártfai; A Somoskövi; C Ködmön; N Szabó; E Puskás; L Kosztolányi; E Faragó; J Mester; L M Parsons; M Salfinger
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.

Authors:  Akos Somoskovi; Qunfeng Song; Judit Mester; Charise Tanner; Yvonne M Hale; Linda M Parsons; Max Salfinger
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay.

Authors:  Isik Somuncu Johansen; Bettina Lundgren; Anaida Sosnovskaja; Vibeke Østergaard Thomsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

7.  Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  M Heep; B Brandstätter; U Rieger; N Lehn; E Richter; S Rüsch-Gerdes; S Niemann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Access to newer laboratory procedures: a call for action.

Authors:  Y M Hale; E P Desmond; K C Jost; M Salfinger
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

9.  Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.

Authors:  Meera Sharma; Sunil Sethi; Baijayantimala Mishra; Caesar Sengupta; S K Sharma
Journal:  Indian J Med Res       Date:  2003-02       Impact factor: 2.375

Review 10.  The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Authors:  A Somoskovi; L M Parsons; M Salfinger
Journal:  Respir Res       Date:  2001-04-05
View more
  19 in total

1.  Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.

Authors:  Janice C Caoili; Angelina Mayorova; David Sikes; Laura Hickman; Bonnie B Plikaytis; Thomas M Shinnick
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility.

Authors:  E Tortoli; F Marcelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

3.  Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding.

Authors:  Soumitesh Chakravorty; Harsheel Kothari; Bola Aladegbami; Eun Jin Cho; Jong Seok Lee; Sandy S Roh; Hyunchul Kim; Hyungkyung Kwak; Eun Gae Lee; Soo Hee Hwang; Padmapriya P Banada; Hassan Safi; Laura E Via; Sang-Nae Cho; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

Review 4.  General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.

Authors:  Md A Gazi; Md R Islam; Mohammad G Kibria; Z Mahmud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-06       Impact factor: 3.267

5.  In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis.

Authors:  Alice Brankin; Marva Seifert; Sophia B Georghiou; Timothy M Walker; Swapna Uplekar; Anita Suresh; Rebecca E Colman
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

Review 6.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 7.  Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care.

Authors:  Vigneshwaran Mani; ShuQi Wang; Fatih Inci; Gennaro De Libero; Amit Singhal; Utkan Demirci
Journal:  Adv Drug Deliv Rev       Date:  2014-06-02       Impact factor: 15.470

8.  Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.

Authors:  Diana Machado; Isabel Couto; João Perdigão; Liliana Rodrigues; Isabel Portugal; Pedro Baptista; Bruno Veigas; Leonard Amaral; Miguel Viveiros
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

9.  HIV-Associated Tuberculosis in the Newborn and Young Infant.

Authors:  M Adhikari; P Jeena; R Bobat; M Archary; K Naidoo; A Coutsoudis; R Singh; N Nair
Journal:  Int J Pediatr       Date:  2011-04-04

10.  Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis.

Authors:  Ritu Singhal; Jyoti Arora; Prabha Lal; Manpreet Bhalla; Vithal Prasad Myneeedu; Digamber Behera
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.